Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma in COVID-19
NCT04332835Phase 3Completed
- Sponsor
- Universidad del Rosario
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Universidad del Rosario. Primary endpoints: Change in Viral Load at 28 days and Change in Immunoglobulin G COVID-19 Titers at 28 days. Started Aug 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04332835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332835.